Predicting Liver-Related In Vitro Endpoints with Machine Learning to Support Early Detection of Drug-Induced Liver Injury
Open Access
- 10 March 2025
- journal article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 38 (4) , 656-671
Abstract
Drug-induced liver injury (DILI) is a major cause of drug development failures and postmarket drug withdrawals, posing significant challenges to public health and pharmaceutical research. The biological mechanisms leading to DILI are highly complex and the adverse reaction is often difficult to foresee. Hence, mechanistic insights into DILI, as well as machine learning models to predict molecular events that trigger adverse outcomes, pharmacokinetics and pharmacodynamics in the liver, are essential tools for understanding and preventing DILI. In this study, we collected a comprehensive data set of 28 in vitro endpoints related to liver toxicity and function, as well as data specific to DILI, to explore the potential of multi-task learning for their prediction. We demonstrate the benefits of ensemble modeling and provide an uncertainty estimation based on the standard deviation of the predictions to define an applicability domain for the models. Available assays at Bayer for two of the endpoints (Bile salt export pump (BSEP) inhibition and phospholipidosis) were run on a set of public compounds and used for further evaluation (data provided in the Supporting Information). Additionally, we conducted an in-depth data analysis of the relationships among the different endpoints, as well as with DILI. The presented models can be used to derive a "Virtual Liver Safety Profile" showcasing the predicted activity of a compound on the selected endpoints to support the prioritization of assays and the elucidation of modes of action.Keywords
Funding Information
- H2020 Health (963845)
This publication has 39 references indexed in Scilit:
- Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approachJournal of Biomedical Informatics, 2023
- Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicityDrug Discovery Today, 2020
- Adverse outcome pathways: a concise introduction for toxicologistsArchives of Toxicology, 2017
- Computational identification of a phospholipidosis toxicophore using 13C and 15N NMR-distance based fingerprintsBioorganic & Medicinal Chemistry, 2014
- Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pumpHepatology, 2014
- The adverse outcome pathway concept: A pragmatic tool in toxicologyToxicology, 2013
- Drug-Induced Liver Injury2013
- Identification of Drugs Inducing Phospholipidosis by Novel in vitro DataChemMedChem, 2012
- Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profileChemico-Biological Interactions, 2010
- A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phaseToxicology in Vitro, 2009